News

Labiotech. eu
labiotech. eu > partner > ai-in-single-cell-analysis

AI in single-cell analysis: solving the interpretation gap

2+ hour, 2+ min ago  (651+ words) Single-cell omics is used across a wide range of drug discovery programs, from target identification to biomarker work and translational studies. The technology has made it possible to look at biology at a much finer resolution, often down to individual…...

Labiotech. eu
labiotech. eu > in-depth > ai-physics

When AI'isn't'enough: How physics is shaping the next wave of drug discovery'

4+ mon, 2+ week ago  (448+ words) A second wave is changing how the industry thinks about AI for drugs. Rather than simply applying generic AI models to databases of known molecules, some companies now look to combine computational physics, structure-based modelling, and generative AI to design…...

Labiotech. eu
labiotech. eu > resource > artificial-intelligence-antibody-discovery

Artificial intelligence and the future of antibody discovery

9+ mon, 3+ week ago  (198+ words) Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is expected to exceed $850 billion worldwide by 2032. Driving forces behind this. .. Artificial intelligence and the future of antibody discovery Discover how AI and ML…...